Related Experiment Video
Updated: Jun 28, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Zolpidem Stimulant Effect and Dependence: A Case Report on Intranasal Use
Branimir Margetić1, Marina Alaber2
1Margetić, MD, PhD., Department of Psychiatry, University Hospital Dubrava, Avenija Gojka Šuška, Zagreb, Croatia.
Intranasal zolpidem (a hypnotic) misuse can cause euphoria and addiction, a rare but emerging issue. This case highlights the risks of non-oral zolpidem use and its potential for dependence.
Area of Science:
- Pharmacology
- Addiction Medicine
- Clinical Case Study
Background:
- Zolpidem is a commonly prescribed hypnotic medication.
- Intranasal misuse of zolpidem is a relatively new phenomenon.
- Dependence linked to euphoria from zolpidem is considered rare.
Observation:
- A 51-year-old polydrug abuser with antisocial personality disorder developed zolpidem dependence.
- The patient exclusively used zolpidem intranasally, consuming up to 500 mg daily.
- Intranasal administration induced euphoria, unlike oral use.
Findings:
- Euphoric effects occurred within 3-5 minutes of intranasal zolpidem administration.
- Severe withdrawal symptoms emerged 7-8 hours after use, relieved by re-administration.
- Dependence was successfully managed via gradual dose reduction (tapering).
Implications:
- Clinicians must recognize the potential for euphoric effects and addiction with intranasal zolpidem.
- This case underscores the risks associated with non-oral routes of zolpidem administration.
- Further research into the misuse potential of intranasal zolpidem is warranted.
Related Concept Videos
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drug Dependence
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...

